Glucagon-like peptide-1 is associated with poor clinical outcome, lipopolysaccharide translocation and inflammation in patients undergoing cardiac surgery with cardiopulmonary bypass
Maxime Nguyen, Annabelle Tavernier, Thomas Gautier, Serge Aho, Marie‐Catherine Morgant, Belaid Bouhemad, Pierre‐Grégoire Guinot, Jacques Grober
Topics & Concepts
Cardiopulmonary bypassMedicineInflammationCardiac surgeryLipopolysaccharideBacterial translocationInternal medicineGlucagon-like peptide-1CardiologyChromosomal translocationIntensive care medicineSurgeryDiabetes mellitusEndocrinologyBiologyBiochemistryType 2 diabetesGeneHyperglycemia and glycemic control in critically ill and hospitalized patientsCardiac and Coronary Surgery TechniquesEnhanced Recovery After Surgery